SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2021-04-01 12:32
Tx date 2021-01-11
$LEXX
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

+273,543 vol
7,399,847
Filed 2021-01-12 17:33
Tx date 2021-01-11
$LEXX
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

+273,543 vol
Filed 2021-02-03 17:43
Tx date 2021-01-11
$LEXX
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
Warrants
37 - Stock split or consolidation
$70,003
+6,667 vol
$10.50 each
206,667
Filed 2021-01-12 17:38
Tx date 2021-01-11
$LEXX
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation
$70,003
+6,667 vol
$10.50 each
Filed 2021-01-12 17:38
Tx date 2021-01-11
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation
$70,003
+6,667 vol
$10.50 each
6,667
Filed 2021-01-12 17:36
Tx date 2021-01-11
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
$237,996
+23,333 vol
$10.20 each
723,333
Filed 2021-01-12 17:34
Tx date 2021-01-11
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

+215,912 vol
6,693,256
Filed 2021-01-12 17:33
Tx date 2021-01-11
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

+273,543 vol
7,399,847
Filed 2020-11-10 16:16
Tx date 2020-11-10
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,799
+25,500 vol
$0.1882 each
6,477,344
Filed 2020-11-10 16:15
Tx date 2020-11-10
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$1,199
+6,000 vol
$0.1999 each
6,451,844
Filed 2020-11-10 16:14
Tx date 2020-11-10
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$1,950
+10,000 vol
$0.195 each
6,445,844
Filed 2020-11-10 16:14
Tx date 2020-11-09
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,391
+22,000 vol
$0.1996 each
6,435,844
Filed 2020-11-10 16:13
Tx date 2020-11-09
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$1,306
+6,500 vol
$0.201 each
6,413,844
Filed 2020-11-10 16:13
Tx date 2020-11-09
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$1,600
+8,000 vol
$0.20 each
6,407,344
Filed 2020-11-10 16:12
Tx date 2020-11-09
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$2,129
+10,000 vol
$0.2129 each
6,399,344
Filed 2020-11-10 16:12
Tx date 2020-11-09
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$2,025
+10,000 vol
$0.2025 each
6,389,344
Filed 2020-11-10 16:11
Tx date 2020-11-09
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$8,062
+37,500 vol
$0.215 each
6,379,344
Filed 2020-11-10 16:08
Tx date 2020-11-06
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$12,306
+60,000 vol
$0.2051 each
6,341,844
Filed 2020-05-11 11:06
Tx date 2020-05-06
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
Warrants
11 - Acquisition or disposition carried out privately
$98,000
+200,000 vol
$0.49 each
200,000
Filed 2020-05-11 11:05
Tx date 2020-05-06
$LXRP
Lexaria Bioscience Corp.
Bunka, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: CAB Financial Services Ltd. (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately
$64,000
+200,000 vol
$0.32 each
6,281,844